Advanced Enzyme Technologies Reports Strong Q2 FY27 Performance Driven by Bio-Processing Growth
Advanced Enzyme Technologies Ltd · Investor Presentation · 31 Oct 2026, 9:18 pm
Advanced Enzyme Technologies Reports Strong Q2 FY27 Performance Driven by Bio-Processing Growth Advanced Enzyme Technologies reported consolidated revenue from operations of ₹2,145 mn for Q2 FY27, up 16% YoY and 12% QoQ, while H1 FY27 revenue rose 10% YoY to ₹4,062 mn. Q2 FY27 EBITDA grew 20% YoY (36% QoQ) to ₹721 mn with a 34% margin, and PAT increased 14% YoY (33% QoQ) to ₹512 mn (24% margin). Growth was led by Industrial Bio-processing (+43% YoY to ₹365 mn) and Animal Nutrition (+37% YoY to ₹265 mn). India contributed 52% of Q2 revenue (+25% YoY).
Original exchange filing (PDF)
More announcements from Advanced Enzyme Technologies Ltd
- Please find enclosed herewith transcript of earnings call held on November 03, 2026 for unaudited financial results for the quarter and half year ended September 30, 2026. · 06 Nov 2026
- Extinguishment of 6,97,582 (Six Lakh Ninety Seven Thousand Five Hundred and Eight Two) fully paid-up Equity Shares of the face value of ? 2/- each (Rupees Two Only) of the Company from .... · 05 Nov 2026
- Please find enclosed herewith the intimation regarding the audio recording of the conference call held on November 03, 2026. · 04 Nov 2026
- Intimation for submission of application to Stock Exchanges for Reclassification from Promoter Group to Public Category pursuant to Regulation 31A of the Securities and Exchange Board of .... · 03 Nov 2026
- Please find enclosed herewith Post Buyback Public Announcement. · 31 Oct 2026
- Please find enclosed herewith press release titled Quarterly Earnings Release dated October 31, 2026. · 31 Oct 2026
- The Board of Directors at their meeting held today i.e. October 31, 2026 have analysed the request received from the Promoter Group members for their reclassification from promoter group .... · 31 Oct 2026
- Advanced enzyme Technologies Limited has informed the exchange about the unaudited financial results (Standalone and Consolidated) of the Company for the quarter and half year ended September .... · 31 Oct 2026
